CG Oncology to Present…

[et_pb_section fb_built=”1″ fullwidth=”on” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_fullwidth_code _builder_version=”4.27.4″ _module_preset=”default” custom_css_free_form=”.breadcrumbs {|| position: fixed;|| left: 0;|| right: 0;|| z-index: 1000;|| display: flex;|| justify-content: center;|| padding: 0 24px;||}||||.breadcrumbs .breadcrumbContainer {|| width: 100%;|| max-width: 1110px;|| margin: 0 auto; || position: relative;||}||||.container {|| width:100% !important;|| padding-top:80px !important||}||.breadcrumbs::after {|| content: %22%22;|| height: 100%;|| width: 135px;|| background: linear-gradient(to left, rgba(255, 255, 255, 1), rgba(255, 255, 255, 0));|| position: absolute;|| right: 0;|| top: 0;||}||||@media (min-width: 1200px) {|| .breadcrumbs .breadcrumbContainer {|| max-width: 1110px;|| }||}||||@media (max-width: 1199px) and (min-width: 992px) {|| .breadcrumbs .breadcrumbContainer {|| max-width: 960px;|| }||}||||@media (max-width: 991px) and (min-width: 768px) {|| .breadcrumbs .breadcrumbContainer{|| max-width: 720px;|| }||}||||@media (max-width: 767px) and (min-width: 576px) {|| .breadcrumbs .breadcrumbContainer {|| max-width: 540px;|| }||}||||@media (max-width: 575px) {|| .breadcrumbs .breadcrumbContainer {|| max-width: 100%;|| }||}” global_colors_info=”{}” theme_builder_area=”post_content”] Home CG Oncology to Present… [/et_pb_fullwidth_code][/et_pb_section][et_pb_section fb_built=”1″ module_id=”pressReleasesWrapper” _builder_version=”4.27.4″ _module_preset=”default” custom_margin=”-100px||||false|false” custom_padding=”0px||||false|false” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” custom_margin=”15px||||false|false” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_heading title=”PRESS RELEASE” module_class=”press-inner-title” _builder_version=”4.27.4″ _module_preset=”default” title_font=”Montserrat|700|||||||” title_text_align=”left” title_text_color=”#2b7de1″ width_tablet=”” width_phone=”276px” width_last_edited=”on|phone” height_tablet=”” height_phone=”34px” height_last_edited=”on|phone” custom_margin=”||||false|false” custom_margin_tablet=”||||false|false” custom_margin_phone=”||||false|false” custom_margin_last_edited=”on|phone” custom_padding=”||||false|false” global_colors_info=”{}” theme_builder_area=”post_content”][/et_pb_heading][et_pb_text content_tablet=”CG Oncology to Present at Upcoming Investor Conferences in May” content_phone=”CG Oncology to Present at Upcoming Investor Conferences in May” content_last_edited=”on|desktop” _builder_version=”4.27.6″ _module_preset=”default” text_font=”Montserrat|700|||||||” text_text_color=”#002169″ text_font_size=”24px” text_line_height=”1.3em” width=”1010px” width_tablet=”1010px” width_phone=”328px” width_last_edited=”on|phone” height=”93px” height_tablet=”93px” height_phone=”317px” height_last_edited=”on|phone” custom_margin_tablet=”” custom_margin_phone=”||||false|false” custom_margin_last_edited=”on|phone” hover_enabled=”0″ text_line_height_tablet=”” text_line_height_phone=”1.3em” text_line_height_last_edited=”on|desktop” global_colors_info=”{}” theme_builder_area=”post_content” sticky_enabled=”0″]CG Oncology to Present at Upcoming Investor Conferences in May[/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row module_class=”audio-player-wrapper” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”]

Listen to this article now

[/et_pb_text][et_pb_code _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”] [/et_pb_code][/et_pb_column][/et_pb_row][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” custom_margin=”0px||||false|false” custom_margin_tablet=”0px||||false|false” custom_margin_phone=”0px||||false|false” custom_margin_last_edited=”on|desktop” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_text content_tablet=”

DALLAS, May 05, 2026 (GLOBE NEWSWIRE) — CG Oncology, Inc. (NASDAQ: CGON) today announced that Arthur Kuan, Chairman & Chief Executive Officer, and Ambaw Bellete, President & Chief Operating Officer, will participate in fireside chat presentations at the Bank of America Health Care Conference and the RBC Capital Markets Global Healthcare Conference this month. The details of the upcoming events are as follows:

Bank of America Health Care Conference 2026 Date: Tuesday, May 12, 2026 Presentation Time: 10:40 AM – 11:10 AM PT Location: Las Vegas, NV

RBC Capital Markets Global Healthcare Conference Date: Wednesday, May 20, 2026 Presentation Time: 2:35 PM – 3:00 PM ET Location: New York, NY

Interested parties may access the live audio webcast for the conferences from the Investor Relations section of the company’s website at www.cgoncology.com . The webcast replays will be available shortly after the conclusion of the live presentations and archived for approximately 90 days.

” content_phone=”

DALLAS, May 05, 2026 (GLOBE NEWSWIRE) — CG Oncology, Inc. (NASDAQ: CGON) today announced that Arthur Kuan, Chairman & Chief Executive Officer, and Ambaw Bellete, President & Chief Operating Officer, will participate in fireside chat presentations at the Bank of America Health Care Conference and the RBC Capital Markets Global Healthcare Conference this month. The details of the upcoming events are as follows:

Bank of America Health Care Conference 2026 Date: Tuesday, May 12, 2026 Presentation Time: 10:40 AM – 11:10 AM PT Location: Las Vegas, NV

RBC Capital Markets Global Healthcare Conference Date: Wednesday, May 20, 2026 Presentation Time: 2:35 PM – 3:00 PM ET Location: New York, NY

Interested parties may access the live audio webcast for the conferences from the Investor Relations section of the company’s website at www.cgoncology.com . The webcast replays will be available shortly after the conclusion of the live presentations and archived for approximately 90 days.

” content_last_edited=”on|desktop” _builder_version=”4.27.6″ _module_preset=”default” text_font=”Montserrat||||||||” text_text_color=”#000000″ text_font_size=”18px” width_tablet=”” width_phone=”329px” width_last_edited=”on|phone” height_tablet=”” height_phone=”1650px” height_last_edited=”on|phone” custom_margin_tablet=”” custom_margin_phone=”10px||||false|false” custom_margin_last_edited=”on|phone” hover_enabled=”0″ custom_css_free_form=”.small-bullet li::marker {|| font-size: 10px; /* adjust size */||}” global_colors_info=”{}” theme_builder_area=”post_content” sticky_enabled=”0″]

DALLAS, May 05, 2026 (GLOBE NEWSWIRE) — CG Oncology, Inc. (NASDAQ: CGON) today announced that Arthur Kuan, Chairman & Chief Executive Officer, and Ambaw Bellete, President & Chief Operating Officer, will participate in fireside chat presentations at the Bank of America Health Care Conference and the RBC Capital Markets Global Healthcare Conference this month. The details of the upcoming events are as follows:

Bank of America Health Care Conference 2026 Date: Tuesday, May 12, 2026 Presentation Time: 10:40 AM – 11:10 AM PT Location: Las Vegas, NV

RBC Capital Markets Global Healthcare Conference Date: Wednesday, May 20, 2026 Presentation Time: 2:35 PM – 3:00 PM ET Location: New York, NY

Interested parties may access the live audio webcast for the conferences from the Investor Relations section of the company’s website at www.cgoncology.com . The webcast replays will be available shortly after the conclusion of the live presentations and archived for approximately 90 days.

[/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” custom_margin=”-30px||||false|false” custom_margin_tablet=”-30px||||false|false” custom_margin_phone=”-10px||||false|false” custom_margin_last_edited=”on|phone” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_text content_tablet=” About CG Oncology CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. CG Oncology sees a world where urologic cancer patients may benefit from our innovative immunotherapies to live with dignity and have an enhanced quality of life. To learn more, please visit: www.cgoncology.com .

CONTACTS: Media Sarah Connors Vice President, Communications and Patient Advocacy, CG Oncology sarah.connors@cgoncology.com

Investor Relations Megan Knight Vice President, Investor Relations, CG Oncology megan.knight@cgoncology.com ” content_phone=” About CG Oncology CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. CG Oncology sees a world where urologic cancer patients may benefit from our innovative immunotherapies to live with dignity and have an enhanced quality of life. To learn more, please visit: www.cgoncology.com .

CONTACTS: Media Sarah Connors Vice President, Communications and Patient Advocacy, CG Oncology sarah.connors@cgoncology.com

Investor Relations Megan Knight Vice President, Investor Relations, CG Oncology megan.knight@cgoncology.com ” content_last_edited=”on|desktop” _builder_version=”4.27.6″ _module_preset=”default” text_font=”Montserrat||||||||” text_text_color=”#000000″ text_font_size=”18px” width_tablet=”” width_phone=”326px” width_last_edited=”on|phone” custom_margin_tablet=”” custom_margin_phone=”-250px||||false|false” custom_margin_last_edited=”on|phone” hover_enabled=”0″ global_colors_info=”{}” theme_builder_area=”post_content” sticky_enabled=”0″] About CG Oncology CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. CG Oncology sees a world where urologic cancer patients may benefit from our innovative immunotherapies to live with dignity and have an enhanced quality of life. To learn more, please visit: www.cgoncology.com .

CONTACTS: Media Sarah Connors Vice President, Communications and Patient Advocacy, CG Oncology sarah.connors@cgoncology.com

Investor Relations Megan Knight Vice President, Investor Relations, CG Oncology megan.knight@cgoncology.com [/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row module_class=”cta-wrapper-row” _builder_version=”4.27.4″ _module_preset=”default” custom_margin=”-30px||||false|false” custom_css_free_form=”.et_post_meta_wrapper{|| display: none;||}” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”][et_pb_divider color=”#ff5100″ module_class=”divider-container” _builder_version=”4.27.4″ _module_preset=”default” custom_margin=”50px||||false|false” custom_margin_tablet=”” custom_margin_phone=”||||false|false” custom_margin_last_edited=”on|phone” global_colors_info=”{}” theme_builder_area=”post_content”][/et_pb_divider][et_pb_code module_class=”cta-wrapper” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”]

Stay Informed Stay Informed

[/et_pb_code][et_pb_code disabled_on=”on|off|off” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}” theme_builder_area=”post_content”]

[/et_pb_code][/et_pb_column][/et_pb_row][/et_pb_section]